Hassan Khalil
Internal Medicine · Washington, DCNPI 1538678297
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,397 of the $4,639 with a category attached, or 73.2%. 22 manufacturers reported payments, led by Medtronic at 35.8% of the total. 2025 is the largest year on record at $2,356, more than ten times the $20 reported in 2019. Among internal medicine clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $49.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AstraZeneca$499
- Amgen$419
- Johnson & Johnson$316
- Alnylam Pharmaceuticals Inc.$268
- Daiichi Sankyo Inc.$232
- plus $1K from 16 others
What the payments were for
- Travel & lodging$1,24227%
- Food & beverage$3,39773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,660 |
| AstraZeneca | 9 | $499 |
| Amgen | 13 | $419 |
| Johnson & Johnson | 5 | $316 |
| Alnylam Pharmaceuticals Inc. | 9 | $268 |
| Daiichi Sankyo Inc. | 9 | $232 |
| Pfizer | 7 | $210 |
| Abiomed | 4 | $171 |
| Penumbra, Inc. | 1 | $143 |
| Boehringer Ingelheim | 5 | $136 |
| Heartflow, Inc. | 1 | $107 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $92 |
| Intuitive Surgical | 1 | $88 |
| Bayer | 4 | $62 |
| Novo Nordisk | 2 | $47 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $25 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| AbbVie | 1 | $20 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,283
- Indigo System$143
- AMVUTTRA$124
- WAINUA$124
- XARELTO$117
- FFRct$107
How this compares
$4,639 in reported general payments places this provider in the 90th percentile of 645 internal medicine providers in District of Columbia.
See all internal medicine providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 11 | $9,514 |
| Metoprolol Succinate | 25 | $313 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 28 | $189 |
| Atorvastatin Calcium | 16 | $128 |
| Spironolactone | 17 | $90 |
| Furosemide | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Washington
- Andrea SingerWashington$850K
- Kathryn SowerwineWashington$831K
- Douglas WardWashington$233K
- Geoffrey GibneyWashington$185K
- Kevin GriffithsWashington$180K
- Bruce RashbaumWashington$86K
- Jessica Wang-MemoliWashington$56K
- Dana McGintyWashington$47K
- Geeta NayyarWashington$46K
- Marie BorumWashington$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.